Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2021-12-08 00:00:00 ET · period of report 2021-12-06 · accession 0001714899-21-000115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-08 | 2021-12-06 | DNLI | Ho Carole | Chief Medical Off | S - Sale | $42.52 | -1,476 | 76.3K | -2% | -$62.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-06 | S | D | 1,476 | $42.52 | 76,316 | D | — | — | (F2) Includes 75,906 restricted stock units. |